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Background: Dengue infection manifests as a wide range of
symptoms, from a mild fever to fatal dengue shock syndrome. The
presenceof four serotypesand infection-enhancingantibodiespose
a challenge to further investigate the role of virus and immune
response in dengue pathogenesis. The serotype of the infecting
virus, viremia and a number of inﬂammatory mediators have been
identiﬁed as risk factors in severe dengue disease but a compre-
hensive analysis of these factors in an Indian cohort has not been
reported.
Methods & Materials: We evaluated the viral and immunolog-
ical factors that correlate with severe dengue disease in a cohort of
pediatric dengue patients in New Delhi. Dengue-infected patients
were enrolled and classiﬁed into three disease severities namely,
Dengue Infection (DI), DenguewithWarning signs (DW)andSevere
Dengue (SD) based on WHO classiﬁcation. Blood samples were col-
lected and the infecting virus serotype and viremia were analysed.
Plasma cytokine levels were estimated by multiplex magnetic-
bead assays. Peripheral blood mononuclear cells were isolated
and dengue positive cells were identiﬁed by staining cell surface
markers and viral antigen and analysis by ﬂouorescence activated
cell sorting technique. Markers of disease severity and recovery
were identiﬁed by computational approaches involving multivari-
ate analysis.
Results: Severe dengue disease was observed in both pri-
mary and secondary infections. Viral load had no association with
disease severity but high viral load correlated with prolonged
thrombocytopenia and delayed recovery. Severe dengue cases had
low Th1 cytokines and a concurrent increase in the inﬂamma-
tory mediators such as IL-6, IL-8 and IL-10. A transient increase
in CD14+CD16+ intermediate monocytes was observed early in
infection. The CD14+ cells, but not the CD16+ or the T or B cells,
were positive for dengue antigen and were major producers of IL-
10. Reduced interferon- levels and enhanced pro-inﬂammatory
cytokines were identiﬁed as some of the distinctive markers of
severe dengue. Furthermore, the cytokines IL-8 and IL-10 were
identiﬁed as the most signiﬁcant markers of recovery from severe
disease.
Conclusion: Our results provide further insights into the
immune response of children to primary and secondary dengue
infection and help us to understand the complex interplay between
the intrinsic factors in dengue pathogenesis.
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Background: Neopterin and sCD14 levels could be detected at
high levels in HBV, HCV and HIV infections as well as patholo-
gies including trauma, sepsis and rheumaoid arthritist. We aimed
to evaluate the importance of neopterin and sCD14 levels for the
determination of HCV infection in situations where low Anti-HCV
reactivity and indeterminate RIBA are present. We also aimed to
compose a new diagnostic perspective for the atypical cases which
have low Anti-HCV reactivity and different RIBA results
Methods & Materials: As Total Study Group (TSG), 70 indi-
viduals with low reactive Anti-HCV test results due to >1-<3,8
signal/cut-off value andwith 30 negative, 30 indeterminate and 10
positiveRIBAresultswere included.AsPatientControlGroup (PCG),
andHealthyControlGroup (HCG), thirty individuals per groupwere
included. ELISA method, HCV RIBA/LIA and HCV-RNA tests were
used. Neopterin and sCD14 levels were measured by competitive
and serological EIA methods
Results: When groups were compared for neopterin levels;
mean neopterin level was found low with advanced signiﬁcant dif-
ference in TSG when compared with PCG, (p <0.001), On the other
hand, no signiﬁcant difference was found between TSG and HCG
(p>0.05), as the levels were close each other. Mean sCD14 level
was found signiﬁcantly higher in TSG thanPCG and HCG (p<005,
p <0,001)
Conclusion: Neopterin levels determined in the cases with low
reactive Anti-HCV and different RIBA patterns could not suggest a
speciﬁc immunoactivation based on HCV infections. We think that
sCD14 test may probably have been non-speciﬁcally affected as a
